JP2017520547A5 - - Google Patents

Download PDF

Info

Publication number
JP2017520547A5
JP2017520547A5 JP2016572800A JP2016572800A JP2017520547A5 JP 2017520547 A5 JP2017520547 A5 JP 2017520547A5 JP 2016572800 A JP2016572800 A JP 2016572800A JP 2016572800 A JP2016572800 A JP 2016572800A JP 2017520547 A5 JP2017520547 A5 JP 2017520547A5
Authority
JP
Japan
Prior art keywords
formula
compound
hydrogen
alkyl
defined above
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016572800A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017520547A (ja
JP6785666B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/063942 external-priority patent/WO2015197534A2/en
Publication of JP2017520547A publication Critical patent/JP2017520547A/ja
Publication of JP2017520547A5 publication Critical patent/JP2017520547A5/ja
Application granted granted Critical
Publication of JP6785666B2 publication Critical patent/JP6785666B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016572800A 2014-06-23 2015-06-22 1,3−ベンゾジオキソール複素環化合物の調製方法 Active JP6785666B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14173397.2 2014-06-23
EP14173397 2014-06-23
PCT/EP2015/063942 WO2015197534A2 (en) 2014-06-23 2015-06-22 Methods for the preparation of 1,3-benzodioxole heterocyclic compounds

Publications (3)

Publication Number Publication Date
JP2017520547A JP2017520547A (ja) 2017-07-27
JP2017520547A5 true JP2017520547A5 (https=) 2018-07-26
JP6785666B2 JP6785666B2 (ja) 2020-11-18

Family

ID=50980952

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016572800A Active JP6785666B2 (ja) 2014-06-23 2015-06-22 1,3−ベンゾジオキソール複素環化合物の調製方法

Country Status (18)

Country Link
US (1) US9908894B2 (https=)
EP (1) EP3157930B1 (https=)
JP (1) JP6785666B2 (https=)
KR (1) KR20170016894A (https=)
CN (1) CN106459081B (https=)
AU (1) AU2015279428B2 (https=)
BR (1) BR112016029510A2 (https=)
CA (1) CA2953284A1 (https=)
DK (1) DK3157930T3 (https=)
ES (1) ES2702451T3 (https=)
IL (1) IL249336A0 (https=)
MX (1) MX2016016378A (https=)
PL (1) PL3157930T3 (https=)
PT (1) PT3157930T (https=)
RU (1) RU2697251C2 (https=)
TW (1) TW201613934A (https=)
WO (1) WO2015197534A2 (https=)
ZA (1) ZA201608442B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3390407T3 (da) 2015-12-18 2023-11-06 Union Therapeutics As Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser
DK3642210T3 (da) * 2017-06-20 2024-12-09 Union Therapeutics As Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser
PT3724196T (pt) 2017-12-15 2023-01-13 Union Therapeutics As Azetidina di-hidrotienopiridinas substituídas e a sua utilização como inibidores de fosfodiesterase
USD914676S1 (en) 2018-05-11 2021-03-30 Samsung Electronics Co., Ltd. Notebook computer
PL3911304T3 (pl) 2019-01-15 2023-12-04 UNION therapeutics A/S Preparat w postaci tabletek o zmodyfikowanym uwalnianiu, zawierający inhibitory fosfodiesterazy
KR20230159485A (ko) 2021-03-22 2023-11-21 유니온 테라퓨틱스 에이/에스 오리스밀라스트를 사용한 화농땀샘염의 치료
GB202205715D0 (en) 2022-04-19 2022-06-01 Union Therapeutics As Treatment of neutrophilic dermatoses
GB202306662D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Dosage regimen
GB202306663D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Combination therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE325110T1 (de) * 1995-05-19 2006-06-15 Kyowa Hakko Kogyo Kk Sauerstoff enthaltende heterocyclische verbindungen
US6514996B2 (en) * 1995-05-19 2003-02-04 Kyowa Hakko Kogyo Co., Ltd. Derivatives of benzofuran or benzodioxole
DE10205274A1 (de) * 2002-02-08 2003-08-21 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen enthaltend neben Anticholinergika heterocyclische Verbindungen
WO2004005276A1 (ja) * 2002-07-03 2004-01-15 Kyowa Hakko Kogyo Co., Ltd. 1,3−ベンゾジオキソール−2−スピロシクロアルカン誘導体の製造法
DE602007012105D1 (de) * 2006-07-14 2011-03-03 Chiesi Farma Spa Derivate von 1-phenyl-2-pyridinylalkylenalkohole als phosphodiesteraseinhibitoren
EP2125736B1 (en) 2006-12-22 2011-03-30 Leo Pharma A/S Substituted acetophenones useful as pde4 inhibitors
UA98639C2 (en) * 2007-02-28 2012-06-11 Лео Фарма А/С Phosphodiesterase inhibitors
CA2676933C (en) * 2007-02-28 2015-09-29 Leo Pharma A/S Novel phosphodiesterase inhibitors
SI3070091T1 (sl) * 2010-06-24 2019-08-30 Leo Pharma A/S Derivati benzodioksola kot zaviralci fosfodiesteraze
WO2014096018A1 (en) * 2012-12-19 2014-06-26 Leo Pharma A/S Methods for the preparation of substituted acetophenones
DK3390407T3 (da) * 2015-12-18 2023-11-06 Union Therapeutics As Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser

Similar Documents

Publication Publication Date Title
JP2017520547A5 (https=)
RU2017101808A (ru) Способы получения 1, 3-бензодиоксольных гетероциклических соединений
JP2025084856A5 (https=)
JP2015524406A5 (https=)
JP2010501516A5 (https=)
JP2017522357A5 (https=)
JP2017501197A5 (https=)
JP2015536898A5 (https=)
JP2017505801A5 (https=)
JP2010513494A5 (https=)
JP2015506943A5 (https=)
CN104803956A (zh) 非罗考昔的一种合成方法
JP2012251113A5 (https=)
EP3222606A1 (en) Carboxylic acid preparation method
CN107434786A (zh) 苯并咪唑化合物及其制备方法
JP2021046426A5 (https=)
JP2017533926A5 (https=)
CN105566260A (zh) 一种呋塞米的制备方法
JP2013525317A5 (https=)
JP2019521165A5 (https=)
JP2016515555A5 (https=)
CN105037319B (zh) 金催化的分子内重氮偶联选择性生成反式大环烯烃的方法
CN103073492A (zh) 2-[3-(s)-[3-[2-(7-氯-2-喹啉基)乙烯基]苯基]-3-羟基丙基]苯甲酸酯的合成方法
CN103724325B (zh) 制备亚磺酰基-1-氢-苯并咪唑衍生物的方法
CN108147993A (zh) 一种水相合成磷钨杂多酸盐的方法